Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07358949 · ClinicalTrials.gov registry record

Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i

A clinical trial, sponsored by Queen's Medical Center.

Not yet
Registry status
70
Enrollment target

NCT07358949: Clinical Trial study, sponsored by Queen's Medical Center.

NCT07358949 is a clinical trial that has not yet begun recruiting, run by Queen's Medical Center. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07358949 has not yet begun recruiting, sponsored by Queen's Medical Center.

NOT YET RECRUITING
Registry status
70 participants
Enrollment target

Study Summary

The purpose of the study is to see if rapid syphilis testing at the time of a family planning (contraception or abortion) visit is acceptable and practical for patients. This study involves a fingerstick blood sample for syphilis testing during a family planning visit. Results will be ready in 10-15 minutes. Potential Benefits * Participants can find out whether they are syphilis positive or negative within the visit, as soon as 10-15 minutes of the finger stick. Typically, syphilis testing results take several days. * If positive, there is the option of starting treatment within the same day. Potential Risks * The study team will do everything possible to protect participants' privacy, including removing names and other identifiable information from study materials, however this is still a small chance there may be a breach of privacy during the study. * Physical risks of fingerstick are exceptionally rare when sterile technique is used. The study team will be using all best practices to reduce risk of infection or injury. * There is a risk of discomfort or pain with fingerstick collection. The risk of scarring is usually only associated with repeat draws, for example in patients with diabetes who have to do fingerstick draws multiple times per day. * There is a very small chance that the positive result is incorrect (also known as a "false positive"), meaning the participant does not actually have syphilis. To confirm the result, the investigators recommend that any positive rapid syphilis result be followed up with a blood test at the lab. Cost for Participation o There is no direct cost to participate in this study. After consent is signed, the participant received renumeration of $50 in form of gift card. If the participant tests positive for a syphilis infection, the participant or their health insurance will be responsible cover the costs of this medical treatment. If they do not have access to health insurance, the study team will connect the particip

Primary Outcome

We will assess feasibility with a combination of quantitative and qualitative methods, in accordance with guidelines put forth by Teresi et al for feasibility pilot studies. Outcomes: * Number of eligible participants * Number of participants who completed SHC testing * Number of participants who agreed to SHC testing * Number of participants able to obtain SHC result * To calculate feasibility, the proportion of all eligible patients who completed testing will be determined. * To calculate co

Interventions

  • DIAGNOSTIC_TEST Rapid Syphilis Test

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2026-03-30
Est. Completion 2027-12
Queen's Medical Center

17 total trials

What is known before NCT07358949 opens enrollment

NCT07358949 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Rapid Syphilis Test is the first listed.

NCT07358949 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07358949 about?

NCT07358949 is a clinical study titled "Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i". The purpose of the study is to see if rapid syphilis testing at the time of a family planning (contraception or abortion) visit is acceptable and practical for patients. This study involves a fingerstick blood sample for syphilis testing during a family planning visit. Results will be ready in 10-1...

What is the current status of trial NCT07358949?

This trial is currently not yet recruiting. The enrollment target is 70 participants. The study started on 2026-03-30. Estimated completion is 2027-12.

What interventions are being tested in trial NCT07358949?

The interventions under investigation include: Rapid Syphilis Test (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07358949?

This trial is sponsored by Queen's Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07358949, the US trial registry maintained by the National Library of Medicine. NCT07358949 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.